BR112022018436A2 - Formas cristalinas de 4-[(7-cloro-2-metoxibenzo[b][1,5]naftiridin-10-il)amino]-2,6-bis(pirrolidin-1-ilmetil)fenol e seus sais - Google Patents

Formas cristalinas de 4-[(7-cloro-2-metoxibenzo[b][1,5]naftiridin-10-il)amino]-2,6-bis(pirrolidin-1-ilmetil)fenol e seus sais

Info

Publication number
BR112022018436A2
BR112022018436A2 BR112022018436A BR112022018436A BR112022018436A2 BR 112022018436 A2 BR112022018436 A2 BR 112022018436A2 BR 112022018436 A BR112022018436 A BR 112022018436A BR 112022018436 A BR112022018436 A BR 112022018436A BR 112022018436 A2 BR112022018436 A2 BR 112022018436A2
Authority
BR
Brazil
Prior art keywords
methoxybenzo
naphthyridin
pyrrolidin
chloro
phenol
Prior art date
Application number
BR112022018436A
Other languages
English (en)
Portuguese (pt)
Inventor
Becker Axel
Gruia Delia-Maria
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR112022018436A2 publication Critical patent/BR112022018436A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022018436A 2020-04-17 2021-04-14 Formas cristalinas de 4-[(7-cloro-2-metoxibenzo[b][1,5]naftiridin-10-il)amino]-2,6-bis(pirrolidin-1-ilmetil)fenol e seus sais BR112022018436A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20170197 2020-04-17
PCT/EP2021/059604 WO2021209477A1 (en) 2020-04-17 2021-04-14 Crystalline forms of 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol and salts thereof

Publications (1)

Publication Number Publication Date
BR112022018436A2 true BR112022018436A2 (pt) 2022-11-01

Family

ID=70333787

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018436A BR112022018436A2 (pt) 2020-04-17 2021-04-14 Formas cristalinas de 4-[(7-cloro-2-metoxibenzo[b][1,5]naftiridin-10-il)amino]-2,6-bis(pirrolidin-1-ilmetil)fenol e seus sais

Country Status (8)

Country Link
US (1) US20230295156A1 (cg-RX-API-DMAC7.html)
EP (1) EP4136087A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023522023A (cg-RX-API-DMAC7.html)
CN (1) CN115515955A (cg-RX-API-DMAC7.html)
BR (1) BR112022018436A2 (cg-RX-API-DMAC7.html)
CA (1) CA3175552A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022552366A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021209477A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100975895B1 (ko) * 2008-04-29 2010-08-18 강민석 피로나리딘의 제조방법 및 이를 위한 중간체
CN101544638B (zh) * 2009-05-12 2012-05-30 重庆通天药业有限公司 乳酸咯萘啶及其药物组合物
CN103373995B (zh) * 2012-04-28 2016-04-27 上海迪赛诺药业有限公司 一种制备咯萘啶的方法
US9994577B2 (en) * 2014-07-04 2018-06-12 Merck Patent Gmbh Azepanyl-derivatives and pharmaceutical compositions comprising the same with antiparasitic activity
CN105461713A (zh) * 2014-09-25 2016-04-06 刘力 苯并萘啶类的新化合物及其组合物和用途
BR112019006456A2 (pt) * 2016-10-13 2019-06-25 Medicines For Malaria Venture Mmv diespiro 1,2,4-trioxolano, formulação farmacêutica, processo para a preparação de um derivado de diespiro 1,2,4-trioxolano, intermediário, e, método para prevenir e/ou tratar malária e esquistossomose ou um câncer.
MX2020009711A (es) * 2018-04-11 2020-10-07 Merck Patent Gmbh Combinacion de quinolin-4-carboxamidas y derivados de benzonaftiridina como combinacion de farmacos antipaludicos.
CN112209926A (zh) * 2019-07-12 2021-01-12 中国中医科学院中药研究所 磷酸咯萘啶的多晶型物及其制备方法、应用
CN116507331A (zh) * 2020-06-15 2023-07-28 默克专利有限公司 Tlr7/8拮抗剂及其用途

Also Published As

Publication number Publication date
CN115515955A (zh) 2022-12-23
WO2021209477A1 (en) 2021-10-21
US20230295156A1 (en) 2023-09-21
EP4136087A1 (en) 2023-02-22
JP2023522023A (ja) 2023-05-26
CA3175552A1 (en) 2021-10-21
PH12022552366A1 (en) 2024-03-18

Similar Documents

Publication Publication Date Title
BR112018071216A2 (pt) inibidores de bromodomínios
CY1122046T1 (el) Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων
CO2021014694A2 (es) Una vacuna de subunidad para el tratamiento o la prevención de una infección del tracto respiratorio
BR112015028873A2 (pt) heteroaril-diidro-pirimidinas interligados na posição 6, para o tratamento e profilaxia de infecção pelo vírus da hepatite b
BR112018009281A2 (pt) composições para tratar atrofia muscular espinhal
BR112015014714A2 (pt) compostos carbamoilpiridona policíclicos e seu uso farmacêutico
CU20150096A7 (es) Compuestos de amida y composición farmacéutica para el tratamiento de vih
BR112018005904A2 (pt) composto, e, método de prevenção e/ou tratamento do hiv.
BR122014013631B8 (pt) compostos antivirais, seu uso e composição farmacêutica compreendendo os mesmos
BR112017015242A2 (pt) compostos de pirazina para o tratamento de enfermidades infecciosas
BR112018013251A2 (pt) compostos heterocílicos tricíclicos fundidos como inibidores da hiv integrase
BR112018005870A2 (pt) composto, e, método de prevenção e/ou tratamento do hiv.
BR112022000963A2 (pt) Método de fabricação de sais de nicotinamida ribofuranosídeo, sais de nicotinamida ribofuranosídeo como tal e usos dos mesmos
BR112015019412A8 (pt) inibidores de bace1, seus usos, e composição farmacêutica
BR112018002689A2 (pt) composto, composição útil e método para tratamento de infecção por hiv
BR112017028456A2 (pt) composto, e, método de prevenção e/ou tratamento de hiv
BR112016013600A2 (pt) Peptídeo antimicrobiano e seus usos
BR112019007591A2 (pt) inibidores de bromodomínios
BR112013001557A2 (pt) composto, composição farmacêutica, métodos para produzir composto e para tratar ou inibir infecção fúngica e/ou parasítica em sujeito e usos de composto e de composição farmacêutica
BR112018011670A2 (pt) compostos antibacterianos
EP4201941A4 (en) PYRAZOLE BORONIC ACID COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND RELATED USES
MX2019008118A (es) Nuevas formas solidas de acetato de[(1s)-1-[(2s,4r,5r)-5-(5-amino- 2-oxo-tiazolo[4,5-d]pirimidin-3-il)-4-hidroxi tetrahidrofuran-2-il]propilo].
BR112021014640A8 (pt) Sais de sulcardina
BR112015004262A2 (pt) compostos de carbamato substituído
BR112022000944A2 (pt) Derivados de di-hidropirimidina e seus usos no tratamento de infecção por hbv ou de doenças induzidas por hbv